Hydrops: Diagnosing & Redefining Outcomes With Precision Study

NAEnrolling by invitationINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

October 11, 2018

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Hydrops FetalisBirth DefectFetal Anomaly
Interventions
DIAGNOSTIC_TEST

Exome sequencing

Expansive genetic test performed for affected fetus or neonate.

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

Fetal Health Foundation

UNKNOWN

lead

University of California, San Francisco

OTHER